ArticleInternational journal of cancer2021

Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.

Paolo Antonio Ascierto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.